Goren Ilan 4
4 · Enlight Renewable Energy Ltd. · Filed May 28, 2026
Research Summary
AI-generated summary of this filing
Enlight (ENLT) GM Ilan Goren Exercises Options, Sells Shares
What Happened
- Ilan Goren, General Manager of Enlight US, exercised 35,286 stock options on 2026-05-27 (exercise cost reported as $23.22/share; total exercise cost ≈ $819,341) and immediately disposed of the resulting shares.
- Of the 35,286 shares acquired, 8,664 were retained/withheld by the company to cover the exercise price and tax liability (valued at $103.76/share, ≈ $898,977). The remaining 26,622 shares were sold in the open market at $103.76/share, generating proceeds of ≈ $2,762,299.
- The filing also reports the related derivative conversion entry (exercise/conversion) for the 35,286 shares.
Key Details
- Transaction date: 2026-05-27; Form 4 filed 2026-05-28 (timely filing).
- Exercise: 35,286 shares at $23.22/share = $819,341 (code M).
- Withholding/payment: 8,664 shares withheld at $103.76/share = $898,977 (code F; company retained shares to cover exercise/tax).
- Open-market sale: 26,622 shares at $103.76/share = $2,762,299 (code S).
- Shares owned after transaction: not specified in the excerpt of the filing provided.
- Notable footnotes: withholding/retention by the company to cover exercise/taxes (F3); dollar amounts converted from NIS using Bank of Israel rates (F1, F4); vesting/grant schedules for options and RSUs are disclosed in the filing (F2, F5, F7, F10).
- No indication this was a scheduled 10b5-1 plan or a late filing.
Context
- This was a cashless-style outcome: options were exercised and enough shares were withheld/sold to satisfy the exercise price and tax withholding; the net result was an open-market sale of 26,622 shares.
- Such transactions are common for insiders to realize value from vested options and to cover tax/Exercise costs; they do not by themselves indicate the insider’s broader view of the company.
Insider Transaction Report
Form 4
Goren Ilan
GENERAL MANAGER, ENLIGHT US
Transactions
- Exercise/Conversion
Ordinary shares, NIS 0.1 par value per share
[F1][F2]2026-05-27$23.22/sh+35,286$819,341→ 78,121 total - Tax Payment
Ordinary shares, NIS 0.1 par value per share
[F3][F4][F2]2026-05-27$103.76/sh−8,664$898,977→ 69,457 total - Sale
Ordinary shares, NIS 0.1 par value per share
[F4][F2]2026-05-27$103.76/sh−26,622$2,762,299→ 42,835 total - Exercise/Conversion
Stock Options (right to buy)
[F1][F5]2026-05-27−35,286→ 29,714 totalExercise: $23.22Exp: 2028-09-30→ Ordinary shares, NIS 0.1 par value per share (35,286 underlying)
Holdings
- 100,000
Stock Options (right to buy)
[F6][F7][F8]Exercise: $22.17Exp: 2029-06-28→ Ordinary shares, NIS 0.1 par value per share (100,000 underlying) - 98,743
Stock Options (right to buy)
[F9][F10][F8]Exercise: $27.33Exp: 2032-07-29→ Ordinary shares, NIS 0.1 par value per share (98,743 underlying)
Footnotes (10)
- [F1]Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
- [F10]Stock options were granted on July 29, 2025, with 24,685 vesting on October 1, 2026; and 24,686 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.
- [F2]Includes (i) 14,083 restricted share units granted on April 21, 2024, with 7,041 vesting on April 21, 2027 and 7,042 vesting on April 21, 2028; and (ii) 21,710 restricted share units granted on July 29, 2025, with 5,427 vesting on each of October 1, 2026 and October 1, 2028, and 5,428 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
- [F3]These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
- [F4]Represents a transaction price of NIS 296.66, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
- [F5]Stock options were granted on September 30, 2021, with 35,000 having vested on September 30, 2024; and 30,000 having vested on September 30, 2025.
- [F6]Represents an exercise price of NIS 68.64, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
- [F7]Stock options were granted on June 28, 2022, with 25,000 having vested on each of June 28, 2023 and June 28, 2024; 35,000 having vested on June 28, 2025; and 15,000 vesting on June 28, 2026.
- [F8]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F9]Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
Signature
By: /s/ Helit Megido as attorney-in-fact for Ilan Goren|2026-05-28